View Older Stories View More Recent Stories

Aug 4, 2015 09:28AM Intec Pharma (NTEC) Prices 5.03M Ordinary Share IPO at $6/Share

Aug 4, 2015 09:25AM Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering

Aug 4, 2015 08:45AM Roth Capital Upgrades Delta Apparel (DLA) to Buy

Aug 3, 2015 02:37PM Roth Capital Affirms TriMas (TRS) at 'Buy' Following Horizon (HZN) Spin; Short-Term Headwinds Mask Robust Potential

Aug 3, 2015 07:31AM Roth Capital Raises Price Target on Web.com Group (WWWW) to $28 Following 2Q15 Results

Aug 3, 2015 07:31AM Roth Capital Downgrades GP Strategies (GPX) to Neutral

Aug 3, 2015 06:38AM Roth Capital Starts General Employment Enterprises (JOB) at Buy

Jul 30, 2015 03:44PM Flamel Technologies (FLML) PT Lifted to $30 at Roth Capital Despite 'Noisy' Quarter

Jul 30, 2015 02:11PM Roth Affirms Sunesis (SNSS) at 'Sell' Following Q2 Report; Risk of Restructuring Remains

Jul 30, 2015 09:34AM Clinton Group Sends Letter To Sphere 3D Board Of Directors

Jul 30, 2015 09:00AM ICON — ICONIX INVESTORS ALERT: Lieff Cabraser Reminds Investors of Upcoming Deadline in Class Action Litigation

Jul 29, 2015 04:15PM Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors

Jul 29, 2015 03:01PM Ligand Pharma (LGND) Becomes 'Value Play' as Viking (VKTX) Advances VK2809 - Roth Capital

Jul 29, 2015 11:01AM Roth Capital Remains Positive on Galena Biopharma (GALE) Following Zuplenz Launch

Jul 29, 2015 07:54AM Roth Capital Raises Price Target on Lemaitre Vascular, Inc. (LMAT) to $14 Following 2Q Earnings

Jul 29, 2015 07:27AM Trinity Biotech (TRIB) PT Lowered to $20 at Roth Capital

Jul 29, 2015 06:41AM Roth Capital Starts Tracon Pharmaceuticals (TCON) at Buy

Jul 29, 2015 06:05AM RedHill Biopharma Reports Results for the Second Quarter of 2015

Jul 28, 2015 05:00PM Pieris Pharmaceuticals Announces Closing of Over-Allotment Option in Public Offering of Common Stock

Jul 28, 2015 02:51PM Roth Capital Positive on Regeneron (REGN) Following 'Impressive' Deal with Sanofi (SNY)'; Affirms at 'Buy'

Jul 28, 2015 12:14PM Streetinsider.com's Hot Lunchtime Reads 7/28: (TWTR) (MU) (MGM) (ESPR)

Jul 28, 2015 11:35AM Lower Taxes, Strong Buybacks Push Plantronics (PLT) to Q1 'Beat' - Roth Capital

Jul 27, 2015 10:58AM Consumer Electronics Giant VIZIO, Inc., Files for $172.5M Common Stock IPO

Jul 27, 2015 09:30AM Roth Capital Cuts Price Target on BioLineRx (BLRX) to $7 Following Data Results

Jul 27, 2015 09:01AM Roth Capital Raises Price Target to $18 on Celator Pharmaceuticals (CPXX) Seeing Share Price Disconnect

Jul 27, 2015 08:57AM Regeneron (REGN) Investors Already Pricing-in Praluent Approval; Roth Capital Affirms at 'Neutral'

Jul 27, 2015 07:55AM Roth Capital Starts Unique Fabricating (UFAB) at Buy

Jul 27, 2015 07:34AM Roth Capital Cuts Price Target on Iconix Brand Group (ICON) to $28 Ahead of 2Q15

Jul 24, 2015 05:31PM VIZIO Files Registration Statement for Initial Public Offering of Class A Common Stock

Jul 24, 2015 02:01PM Roth Capital Remains Bullish on Ligand Pharma (LGND) Following FDA Approval of Kyprolis sNDA (AMGN)

Jul 24, 2015 09:21AM Roth Affirms Keryx Biopharma (KERX) at 'Buy'; CHMP Opinion on Fexeric Not Unexpected

Jul 24, 2015 07:32AM Roth Capital Downgrades Sunesis Pharmaceuticals Inc. (SNSS) to Sell, $1 PT

Jul 24, 2015 06:58AM Roth Capital Upgrades IGI Laboratories (IG) to Buy; Sees 2016 at Break-Out Year

Jul 23, 2015 01:53PM UPDATE: Keryx Biopharmaceuticals (KERX) PT Cut to $11 at Roth Capital; Auryxia In Major 'Show Me' Phase

Jul 22, 2015 03:44PM Notable 52-Week Highs and Lows 7/22: (EXEL) (DVAX) (ABT) High; (XOMA) (CZR) (BEAV) Low

Jul 22, 2015 12:51PM Unusual 11 Mid-Day Movers 7/22: (SLTD) (LPCN) (BZUN) Higher; (XOMA) (ANGI) (CZR) Lower

Jul 22, 2015 10:20AM Notable Analyst Rating Changes 7/22: (AMZN) (AUY) (JCP) Upgraded; (ABG) (UTC) (CHK) Downgraded

Jul 22, 2015 10:10AM RedHill Biopharma Announces Closing of Public Offering of Its American Depository Shares

Jul 22, 2015 09:30AM Pre-Open Stock Movers 07/22: (ISRG) (THOR) (EYES) Higher; (XOMA) (ILMN) (AAPL) Lower (more...)

Jul 22, 2015 09:16AM Roth Capital Raises Price Target on Neogen Corp (NEOG) Following 4Q15 Results

Jul 22, 2015 08:04AM Roth Capital Starts Lipocine Inc (LPCN) at Buy, $36 PT

Jul 22, 2015 07:37AM Roth Capital Starts Pieris Pharmaceuticals (PIRS) at Buy

Jul 21, 2015 11:44AM NeuroDerm Ltd. Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Jul 21, 2015 11:44AM NeuroDerm Ltd. Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Jul 21, 2015 09:00AM Roth Affirms Ligand Pharma (LGND) at 'Buy'; Promacta Q2 Revenue Outpaces Expectations (NVS)

Jul 21, 2015 08:31AM 4th Annual Gateway Conference to Showcase More Than 80 Growth Companies in San Francisco on September 9-10

Jul 20, 2015 09:00AM ROTH Capital Partners Expands Healthcare Banking Practice with Addition of Adam Stormoen as a Director, Investment Banking

Jul 20, 2015 07:45AM Cempra (CEMP) PT Raised to $56 at Roth Capital; Solithromycin Positioned to Eclipse Macrolides in COPD

Jul 17, 2015 12:00PM Tonix Pharmaceuticals Closes $20.1 Million Public Offering of Common Stock

Jul 17, 2015 11:00AM Vermillion, Inc. Announces Closing of $18.8 Million Public Offering of Common Stock

View More Recent Stories View Older Stories